United States Competent Cells Market Report 2017

Publisher Name :
Date: 25-Dec-2017
No. of pages: 116
Inquire Before Buying

In this report, the United States Competent Cells market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:

- The West

- Southwest

- The Middle Atlantic

- New England

- The South

- The Midwest

with sales (volume), revenue (value), market share and growth rate of Competent Cells in these regions, from 2012 to 2022 (forecast).

United States Competent Cells market competition by top manufacturers/players, with Competent Cells sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

- Merck KGaA (Germany)

- Promega Corporation (U.S.)

- Thermo Fisher Scientific, Inc. (U.S)

- New England Biolabs (U.S.)

- Takara Bio (Japan)

- Agilent Technologies (U.S.)

- Lucigen (U.S.)

- QIAGEN N.V. (Germany)

- OriGene Technologies (U.S.)

- Bioline (U.K.)

- Zymo Research (U.S.)

- Beijing TransGen Biotech Co., Ltd. (China)

- Source BioScience (U.K.)

- IBA GmBH (Germany)

- Genewiz (U.S.)

- BioDynamics Laboratory, Inc. (Japan)

- GCC Biotech (India)

- SMOBIO Technology (Taiwan)

- GeneScript Corporation (U.S.)

- Bio-Rad Laboratories (U.S.)

- Life Technologies (India) Pvt. Ltd.

- Cell Applications, Inc. (U.S.)

- Delphi Genetics (Belgium)

- Scarab Genomics, LLC (U.S.)

- Yeastern Biotech Co., Ltd. (Taiwan)

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

- Chemically Competent Cells

- Electrocompetent Cells

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

- Pharmaceutical and Biotechnology Companies

- Academic Research Institutes

- Contract Research Organizations (CROs)

If you have any special requirements, please let us know and we will offer you the report as you want.

United States Competent Cells Market Report 2017

Table of Contents
United States Competent Cells Market Report 2017
1 Competent Cells Overview
1.1 Product Overview and Scope of Competent Cells
1.2 Classification of Competent Cells by Product Category
1.2.1 United States Competent Cells Market Size (Sales Volume) Comparison by Type (2012-2022)
1.2.2 United States Competent Cells Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
1.2.3 Chemically Competent Cells
1.2.4 Electrocompetent Cells
1.3 United States Competent Cells Market by Application/End Users
1.3.1 United States Competent Cells Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
1.3.2 Pharmaceutical and Biotechnology Companies
1.3.3 Academic Research Institutes
1.3.4 Contract Research Organizations (CROs)
1.4 United States Competent Cells Market by Region
1.4.1 United States Competent Cells Market Size (Value) Comparison by Region (2012-2022)
1.4.2 The West Competent Cells Status and Prospect (2012-2022)
1.4.3 Southwest Competent Cells Status and Prospect (2012-2022)
1.4.4 The Middle Atlantic Competent Cells Status and Prospect (2012-2022)
1.4.5 New England Competent Cells Status and Prospect (2012-2022)
1.4.6 The South Competent Cells Status and Prospect (2012-2022)
1.4.7 The Midwest Competent Cells Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Competent Cells (2012-2022)
1.5.1 United States Competent Cells Sales and Growth Rate (2012-2022)
1.5.2 United States Competent Cells Revenue and Growth Rate (2012-2022)
2 United States Competent Cells Market Competition by Players/Suppliers
2.1 United States Competent Cells Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Competent Cells Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Competent Cells Average Price by Players/Suppliers (2012-2017)
2.4 United States Competent Cells Market Competitive Situation and Trends
2.4.1 United States Competent Cells Market Concentration Rate
2.4.2 United States Competent Cells Market Share of Top 3 and Top 5 Players/Suppliers
2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Competent Cells Manufacturing Base Distribution, Sales Area, Product Type
3 United States Competent Cells Sales (Volume) and Revenue (Value) by Region (2012-2017)
3.1 United States Competent Cells Sales and Market Share by Region (2012-2017)
3.2 United States Competent Cells Revenue and Market Share by Region (2012-2017)
3.3 United States Competent Cells Price by Region (2012-2017)
4 United States Competent Cells Sales (Volume) and Revenue (Value) by Type (Product Category) (2012-2017)
4.1 United States Competent Cells Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Competent Cells Revenue and Market Share by Type (2012-2017)
4.3 United States Competent Cells Price by Type (2012-2017)
4.4 United States Competent Cells Sales Growth Rate by Type (2012-2017)
5 United States Competent Cells Sales (Volume) by Application (2012-2017)
5.1 United States Competent Cells Sales and Market Share by Application (2012-2017)
5.2 United States Competent Cells Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities
6 United States Competent Cells Players/Suppliers Profiles and Sales Data
6.1 Merck KGaA (Germany)
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Competent Cells Product Category, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 Merck KGaA (Germany) Competent Cells Sales, Revenue, Price and Gross Margin (2012-2017)
6.1.4 Main Business/Business Overview
6.2 Promega Corporation (U.S.)
6.2.2 Competent Cells Product Category, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 Promega Corporation (U.S.) Competent Cells Sales, Revenue, Price and Gross Margin (2012-2017)
6.2.4 Main Business/Business Overview
6.3 Thermo Fisher Scientific, Inc. (U.S)
6.3.2 Competent Cells Product Category, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 Thermo Fisher Scientific, Inc. (U.S) Competent Cells Sales, Revenue, Price and Gross Margin (2012-2017)
6.3.4 Main Business/Business Overview
6.4 New England Biolabs (U.S.)
6.4.2 Competent Cells Product Category, Application and Specification
6.4.2.1 Product A
6.4.2.2 Product B
6.4.3 New England Biolabs (U.S.) Competent Cells Sales, Revenue, Price and Gross Margin (2012-2017)
6.4.4 Main Business/Business Overview
6.5 Takara Bio (Japan)
6.5.2 Competent Cells Product Category, Application and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 Takara Bio (Japan) Competent Cells Sales, Revenue, Price and Gross Margin (2012-2017)
6.5.4 Main Business/Business Overview
6.6 Agilent Technologies (U.S.)
6.6.2 Competent Cells Product Category, Application and Specification
6.6.2.1 Product A
6.6.2.2 Product B
6.6.3 Agilent Technologies (U.S.) Competent Cells Sales, Revenue, Price and Gross Margin (2012-2017)
6.6.4 Main Business/Business Overview
6.7 Lucigen (U.S.)
6.7.2 Competent Cells Product Category, Application and Specification
6.7.2.1 Product A
6.7.2.2 Product B
6.7.3 Lucigen (U.S.) Competent Cells Sales, Revenue, Price and Gross Margin (2012-2017)
6.7.4 Main Business/Business Overview
6.8 QIAGEN N.V. (Germany)
6.8.2 Competent Cells Product Category, Application and Specification
6.8.2.1 Product A
6.8.2.2 Product B
6.8.3 QIAGEN N.V. (Germany) Competent Cells Sales, Revenue, Price and Gross Margin (2012-2017)
6.8.4 Main Business/Business Overview
6.9 OriGene Technologies (U.S.)
6.9.2 Competent Cells Product Category, Application and Specification
6.9.2.1 Product A
6.9.2.2 Product B
6.9.3 OriGene Technologies (U.S.) Competent Cells Sales, Revenue, Price and Gross Margin (2012-2017)
6.9.4 Main Business/Business Overview
6.10 Bioline (U.K.)
6.10.2 Competent Cells Product Category, Application and Specification
6.10.2.1 Product A
6.10.2.2 Product B
6.10.3 Bioline (U.K.) Competent Cells Sales, Revenue, Price and Gross Margin (2012-2017)
6.10.4 Main Business/Business Overview
6.11 Zymo Research (U.S.)
6.12 Beijing TransGen Biotech Co., Ltd. (China)
6.13 Source BioScience (U.K.)
6.14 IBA GmBH (Germany)
6.15 Genewiz (U.S.)
6.16 BioDynamics Laboratory, Inc. (Japan)
6.17 GCC Biotech (India)
6.18 SMOBIO Technology (Taiwan)
6.19 GeneScript Corporation (U.S.)
6.20 Bio-Rad Laboratories (U.S.)
6.21 Life Technologies (India) Pvt. Ltd.
6.22 Cell Applications, Inc. (U.S.)
6.23 Delphi Genetics (Belgium)
6.24 Scarab Genomics, LLC (U.S.)
6.25 Yeastern Biotech Co., Ltd. (Taiwan)
7 Competent Cells Manufacturing Cost Analysis
7.1 Competent Cells Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Competent Cells
8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Competent Cells Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Competent Cells Major Manufacturers in 2016
8.4 Downstream Buyers
9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List
10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change
11 United States Competent Cells Market Size (Value and Volume) Forecast (2017-2022)
11.1 United States Competent Cells Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Competent Cells Sales Volume Forecast by Type (2017-2022)
11.3 United States Competent Cells Sales Volume Forecast by Application (2017-2022)
11.4 United States Competent Cells Sales Volume Forecast by Region (2017-2022)
12 Research Findings and Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
List of Tables and Figures
Figure Product Picture of Competent Cells
Figure United States Competent Cells Market Size (K MT) by Type (2012-2022)
Figure United States Competent Cells Sales Volume Market Share by Type (Product Category) in 2016
Figure Chemically Competent Cells Product Picture
Figure Electrocompetent Cells Product Picture
Figure United States Competent Cells Market Size (K MT) by Application (2012-2022)
Figure United States Sales Market Share of Competent Cells by Application in 2016
Figure Pharmaceutical and Biotechnology Companies Examples
Table Key Downstream Customer in Pharmaceutical and Biotechnology Companies
Figure Academic Research Institutes Examples
Table Key Downstream Customer in Academic Research Institutes
Figure Contract Research Organizations (CROs) Examples
Table Key Downstream Customer in Contract Research Organizations (CROs)
Figure United States Competent Cells Market Size (Million USD) by Region (2012-2022)
Figure The West Competent Cells Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Competent Cells Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Competent Cells Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Competent Cells Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Competent Cells Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Competent Cells Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Competent Cells Sales (K MT) and Growth Rate (2012-2022)
Figure United States Competent Cells Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Competent Cells Market Major Players Product Sales Volume (K MT) (2012-2017)
Table United States Competent Cells Sales (K MT) of Key Players/Suppliers (2012-2017)
Table United States Competent Cells Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Competent Cells Sales Share by Players/Suppliers
Figure 2017 United States Competent Cells Sales Share by Players/Suppliers
Figure United States Competent Cells Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Competent Cells Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Competent Cells Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Competent Cells Revenue Share by Players/Suppliers
Figure 2017 United States Competent Cells Revenue Share by Players/Suppliers
Table United States Market Competent Cells Average Price (USD/MT) of Key Players/Suppliers (2012-2017)
Figure United States Market Competent Cells Average Price (USD/MT) of Key Players/Suppliers in 2016
Figure United States Competent Cells Market Share of Top 3 Players/Suppliers
Figure United States Competent Cells Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Competent Cells Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Competent Cells Product Category
Table United States Competent Cells Sales (K MT) by Region (2012-2017)
Table United States Competent Cells Sales Share by Region (2012-2017)
Figure United States Competent Cells Sales Share by Region (2012-2017)
Figure United States Competent Cells Sales Market Share by Region in 2016
Table United States Competent Cells Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Competent Cells Revenue Share by Region (2012-2017)
Figure United States Competent Cells Revenue Market Share by Region (2012-2017)
Figure United States Competent Cells Revenue Market Share by Region in 2016
Table United States Competent Cells Price (USD/MT) by Region (2012-2017)
Table United States Competent Cells Sales (K MT) by Type (2012-2017)
Table United States Competent Cells Sales Share by Type (2012-2017)
Figure United States Competent Cells Sales Share by Type (2012-2017)
Figure United States Competent Cells Sales Market Share by Type in 2016
Table United States Competent Cells Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Competent Cells Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Competent Cells by Type (2012-2017)
Figure Revenue Market Share of Competent Cells by Type in 2016
Table United States Competent Cells Price (USD/MT) by Types (2012-2017)
Figure United States Competent Cells Sales Growth Rate by Type (2012-2017)
Table United States Competent Cells Sales (K MT) by Application (2012-2017)
Table United States Competent Cells Sales Market Share by Application (2012-2017)
Figure United States Competent Cells Sales Market Share by Application (2012-2017)
Figure United States Competent Cells Sales Market Share by Application in 2016
Table United States Competent Cells Sales Growth Rate by Application (2012-2017)
Figure United States Competent Cells Sales Growth Rate by Application (2012-2017)
Table Merck KGaA (Germany) Basic Information List
Table Merck KGaA (Germany) Competent Cells Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Merck KGaA (Germany) Competent Cells Sales Growth Rate (2012-2017)
Figure Merck KGaA (Germany) Competent Cells Sales Market Share in United States (2012-2017)
Figure Merck KGaA (Germany) Competent Cells Revenue Market Share in United States (2012-2017)
Table Promega Corporation (U.S.) Basic Information List
Table Promega Corporation (U.S.) Competent Cells Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Promega Corporation (U.S.) Competent Cells Sales Growth Rate (2012-2017)
Figure Promega Corporation (U.S.) Competent Cells Sales Market Share in United States (2012-2017)
Figure Promega Corporation (U.S.) Competent Cells Revenue Market Share in United States (2012-2017)
Table Thermo Fisher Scientific, Inc. (U.S) Basic Information List
Table Thermo Fisher Scientific, Inc. (U.S) Competent Cells Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Thermo Fisher Scientific, Inc. (U.S) Competent Cells Sales Growth Rate (2012-2017)
Figure Thermo Fisher Scientific, Inc. (U.S) Competent Cells Sales Market Share in United States (2012-2017)
Figure Thermo Fisher Scientific, Inc. (U.S) Competent Cells Revenue Market Share in United States (2012-2017)
Table New England Biolabs (U.S.) Basic Information List
Table New England Biolabs (U.S.) Competent Cells Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure New England Biolabs (U.S.) Competent Cells Sales Growth Rate (2012-2017)
Figure New England Biolabs (U.S.) Competent Cells Sales Market Share in United States (2012-2017)
Figure New England Biolabs (U.S.) Competent Cells Revenue Market Share in United States (2012-2017)
Table Takara Bio (Japan) Basic Information List
Table Takara Bio (Japan) Competent Cells Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Takara Bio (Japan) Competent Cells Sales Growth Rate (2012-2017)
Figure Takara Bio (Japan) Competent Cells Sales Market Share in United States (2012-2017)
Figure Takara Bio (Japan) Competent Cells Revenue Market Share in United States (2012-2017)
Table Agilent Technologies (U.S.) Basic Information List
Table Agilent Technologies (U.S.) Competent Cells Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Agilent Technologies (U.S.) Competent Cells Sales Growth Rate (2012-2017)
Figure Agilent Technologies (U.S.) Competent Cells Sales Market Share in United States (2012-2017)
Figure Agilent Technologies (U.S.) Competent Cells Revenue Market Share in United States (2012-2017)
Table Lucigen (U.S.) Basic Information List
Table Lucigen (U.S.) Competent Cells Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Lucigen (U.S.) Competent Cells Sales Growth Rate (2012-2017)
Figure Lucigen (U.S.) Competent Cells Sales Market Share in United States (2012-2017)
Figure Lucigen (U.S.) Competent Cells Revenue Market Share in United States (2012-2017)
Table QIAGEN N.V. (Germany) Basic Information List
Table QIAGEN N.V. (Germany) Competent Cells Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure QIAGEN N.V. (Germany) Competent Cells Sales Growth Rate (2012-2017)
Figure QIAGEN N.V. (Germany) Competent Cells Sales Market Share in United States (2012-2017)
Figure QIAGEN N.V. (Germany) Competent Cells Revenue Market Share in United States (2012-2017)
Table OriGene Technologies (U.S.) Basic Information List
Table OriGene Technologies (U.S.) Competent Cells Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure OriGene Technologies (U.S.) Competent Cells Sales Growth Rate (2012-2017)
Figure OriGene Technologies (U.S.) Competent Cells Sales Market Share in United States (2012-2017)
Figure OriGene Technologies (U.S.) Competent Cells Revenue Market Share in United States (2012-2017)
Table Bioline (U.K.) Basic Information List
Table Bioline (U.K.) Competent Cells Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Bioline (U.K.) Competent Cells Sales Growth Rate (2012-2017)
Figure Bioline (U.K.) Competent Cells Sales Market Share in United States (2012-2017)
Figure Bioline (U.K.) Competent Cells Revenue Market Share in United States (2012-2017)
Table Zymo Research (U.S.) Basic Information List
Table Beijing TransGen Biotech Co., Ltd. (China) Basic Information List
Table Source BioScience (U.K.) Basic Information List
Table IBA GmBH (Germany) Basic Information List
Table Genewiz (U.S.) Basic Information List
Table BioDynamics Laboratory, Inc. (Japan) Basic Information List
Table GCC Biotech (India) Basic Information List
Table SMOBIO Technology (Taiwan) Basic Information List
Table GeneScript Corporation (U.S.) Basic Information List
Table Bio-Rad Laboratories (U.S.) Basic Information List
Table Life Technologies (India) Pvt. Ltd. Basic Information List
Table Cell Applications, Inc. (U.S.) Basic Information List
Table Delphi Genetics (Belgium) Basic Information List
Table Scarab Genomics, LLC (U.S.) Basic Information List
Table Yeastern Biotech Co., Ltd. (Taiwan) Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Competent Cells
Figure Manufacturing Process Analysis of Competent Cells
Figure Competent Cells Industrial Chain Analysis
Table Raw Materials Sources of Competent Cells Major Players/Suppliers in 2016
Table Major Buyers of Competent Cells
Table Distributors/Traders List
Figure United States Competent Cells Sales Volume (K MT) and Growth Rate Forecast (2017-2022)
Figure United States Competent Cells Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Competent Cells Price (USD/MT) Trend Forecast (2017-2022)
Table United States Competent Cells Sales Volume (K MT) Forecast by Type (2017-2022)
Figure United States Competent Cells Sales Volume (K MT) Forecast by Type (2017-2022)
Figure United States Competent Cells Sales Volume (K MT) Forecast by Type in 2022
Table United States Competent Cells Sales Volume (K MT) Forecast by Application (2017-2022)
Figure United States Competent Cells Sales Volume (K MT) Forecast by Application (2017-2022)
Figure United States Competent Cells Sales Volume (K MT) Forecast by Application in 2022
Table United States Competent Cells Sales Volume (K MT) Forecast by Region (2017-2022)
Table United States Competent Cells Sales Volume Share Forecast by Region (2017-2022)
Figure United States Competent Cells Sales Volume Share Forecast by Region (2017-2022)
Figure United States Competent Cells Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
  • Global Organs-on-chips Market Research Report 2018
    Published: 18-Jul-2018        Price: US 2900 Onwards        Pages: 98
    This report studies the global Organs-on-chips market status and forecast, categorizes the global Organs-on-chips market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in United States, Europe, China, Japan, South Korea and Taiwan and other regions. The global Organs-on-chips market is valued at million US$ in 2017 and will reach million US$ by the end of 2025, growing at a CAGR of during 2018-2025. ......
  • 2018-2023 Global DNA Forensic Consumption Market Report
    Published: 17-Jul-2018        Price: US 4660 Onwards        Pages: 165
    In this report, LP Information covers the present scenario (with the base year being 2017) and the growth prospects of global DNA Forensic market for 2018-2023. DNA forensics is a branch of forensic science that focuses on the use of genetic material in criminal investigation to answer questions pertaining to legal situations, including criminal and civil cases. The DNA forensics market will continue to be led by the sectors with applications in legal, law enforcement and ......
  • 2018 Top 5 DNA Forensic Players in North America, Europe, Asia-Pacific, South America, Middle East and Africa
    Published: 17-Jul-2018        Price: US 4960 Onwards        Pages: 142
    DNA forensics is a branch of forensic science that focuses on the use of genetic material in criminal investigation to answer questions pertaining to legal situations, including criminal and civil cases. The DNA forensics market will continue to be led by the sectors with applications in legal, law enforcement and biodefense environments. Gradually, the balance should shift; as therapeutics derived from forensics origins or incorporated into pharmacogenomic medicines assert a more domina......
  • Global Human Microbiome Market by Manufacturers, Countries, Type and Application, Forecast to 2023
    Published: 17-Jul-2018        Price: US 3480 Onwards        Pages: 145
    The Human Microbiome is the collection of all the microorganisms living in association with the human body. These communities consist of a variety of microorganisms including eukaryotes, archaea, bacteria and viruses. Bacteria in an average human body number ten times more than human cells, for a total of about 1000 more genes than are present in the human genome. Because of their small size, however, microorganisms make up only about 1 to 3 percent of our body mass (that's 2 to 6 pounds of bact......
  • Peptide Synthesis Market by Product (Reagent, Synthesizer, Chromatography), Technology (Solid Phase, Liquid Phase, and Hybrid & Recombinant), End User (Pharmaceuticals & Biotechnology, CRO), and Region - Global Forecast to 2023
    Published: 16-Jul-2018        Price: US 5650 Onwards        Pages: 135
    “The peptide synthesis market is projected to grow at a CAGR of 6.5% in the next five years” The peptide synthesis market is projected to reach USD 426.4million by 2023 from USD 310.5 million in 2018, at a CAGR of 6.5% during the forecast period. Factors such as increasing use of peptides in pharmaceutical drugs, increase in research activities and availability of funding for R&D, and the development of advanced peptide synthesizers are expected to dri......
  • Global Antibody Services Market by Manufacturers, Countries, Type and Application, Forecast to 2023
    Published: 16-Jul-2018        Price: US 3480 Onwards        Pages: 147
    Antibody services include competitively priced packages and purification options for antibody production. Service Providers offer support for different types and steps of antibody production—from peptide design, synthesis, and carrier protein conjugation to animal immunization, serum collection, or hybridoma fusion, titer analysis, and final antibody purification. They also immunize with recombinant proteins or protein fragments provided by the customers(or expressed and purified in labs using c......
  • Global and United States Microfluidics Market Research by Company, Type & Application 2013-2025
    Published: 14-Jul-2018        Price: US 2000 Onwards        Pages: 124
    Summary Market Segment as follows: By Type - Polymer-Based Microfluidics - Glass-Based Microfluidics - Silicon-Based Microfluidics - Other Materials-Based (Paper & Ceramics) Microfluidics By Application - Pharmaceutical Research - In Vitro Diagnostics - Drug Delivery By Company - Perkinelmer, Inc. - Cepheid, Inc. - Abbott Laboratories, Inc. - Thermo Fisher Scientific, Inc. - Agilent Te......
  • Global and United States Separation Systems for Commercial Biotechnology Market Research by Company, Type & Application 2013-2025
    Published: 13-Jul-2018        Price: US 2000 Onwards        Pages: 142
    Summary Market Segment as follows: By Type - Microarray - Lab-on-a-chip - Biochip - Magnetic separation - Chromatography - Flow cytometry - Membrane filtration - Electrophoresis - Centrifugation By Application - Pharmaceutical - Food & Cosmetics - Agriculture - Others By Company - Thermo Fisher Scientific - GE Healthcare - Agilent Technologies;Shimadzu Corpo......
  • Global and United States Protein Crystallography Product Market Research by Company, Type & Application 2013-2025
    Published: 12-Jul-2018        Price: US 2000 Onwards        Pages: 117
    Summary Market Segment as follows: By Type Instruments Reagents/Consumables Services & Software By Application Pharmaceutical Companies Biotechnology Companies Government Institutes Academic Institutions By Company Rigaku Corporation (Japan) Hampton Research (U.S.) Jena Bioscience GmbH (Germany) Molecular Dimensions Ltd. (U.K.) Formulatrix, Inc. (U.S.)......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs